metformin and axitinib

metformin has been researched along with axitinib in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ	1
Hayward, R; Marais, R; Martin, MJ; Viros, A	1

Other Studies

2 other study(ies) available for metformin and axitinib

Article	Year
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15 Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship	2013
Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A. Cancer discovery, 2012, Volume: 2, Issue:4 Topics: AMP-Activated Protein Kinases; Animals; Axitinib; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Indazoles; Melanoma; Metformin; Mice; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Ribosomal Protein S6 Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2012

Article

Year

Identification of potent Yes1 kinase inhibitors using a library screening approach.

Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013

Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A.

Cancer discovery, 2012, Volume: 2, Issue:4

Topics: AMP-Activated Protein Kinases; Animals; Axitinib; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Indazoles; Melanoma; Metformin; Mice; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Ribosomal Protein S6 Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012